James Bearden to Prostatic Neoplasms
This is a "connection" page, showing publications James Bearden has written about Prostatic Neoplasms.
Connection Strength
0.403
-
Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trial. JAMA Ophthalmol. 2015 Jan; 133(1):17-24.
Score: 0.081
-
An evaluation of a community-academic-clinical partnership to reduce prostate cancer disparities in the South. J Cancer Educ. 2014 Mar; 29(1):80-5.
Score: 0.077
-
Developing partnerships and recruiting dyads for a prostate cancer informed decision making program: lessons learned from a community-academic-clinical team. J Cancer Educ. 2012 Jun; 27(2):243-9.
Score: 0.068
-
Combination therapy of recurrent prostate cancer with the proteasome inhibitor bortezomib plus hormone blockade. Cancer Biol Ther. 2011 Jul 15; 12(2):119-24.
Score: 0.064
-
Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB. J Support Oncol. 2010 May-Jun; 8(3):128-32.
Score: 0.059
-
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009 Jan 07; 301(1):39-51.
Score: 0.053